Congress trades
Globus Medical, Inc. (GMED)
About Globus Medical, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Keith W. Pfeil
- Employees
- 6,000
- Listed since
- Aug 3, 2012
- Market value
- $10.1B
- Price to earnings
- 18.8
- Earnings per share
- $3.96
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | $1.34 | $1.10 | $789.6M | $782.9M | EPS beatRevenue in line |
| Q1 FY2026reported May 7, 2026 | $1.12 | $0.92 | $759.9M | $740.3M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 24, 2026 | $1.28 | $1.06 | $826.4M | $801.7M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 6, 2025 | $1.18 | $0.78 | $769.0M | $734.7M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 7, 2025 | $0.86 | $0.76 | $745.3M | $742.7M | EPS beatRevenue in line |
| Q1 FY2025reported May 8, 2025 | $0.68 | $0.74 | $598.1M | $625.9M | EPS missRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 24, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Keith W. PfeilChief Executive Officer and President | $479K | $0 | $3.9M | $4.4M |
| David C. PaulChairman of the Board of Directors and Executive Chair | $469K | $0 | $3.8M | $4.3M |
| Kelly G. HullerExecutive Vice President, General Counsel and Corporat | $364K | $0 | $1.9M | $2.3M |
| Kyle R KlineSenior Vice President and Chief Financial Officer | $334K | $0 | $1.0M | $1.4M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $853.8M | 10,806,724 | +2.9% | 7.98% |
| Jupiter Topco LLC | $647.9M | 8,200,423 | +100.0% | 6.06% |
| Vanguard Capital Management LLC | $403.5M | 5,107,532 | +1.5% | 3.77% |
| Vanguard Portfolio Management LLC | $394.6M | 4,994,385 | +2.4% | 3.69% |
| Invesco Ltd. | $340.5M | 4,309,771 | -0.2% | 3.18% |
| Kayne Anderson Rudnick Investment Management LLC | $338.1M | 4,279,730 | +100.0% | 3.16% |
| State Street Corp | $293.5M | 3,714,029 | +3.4% | 2.74% |
| Sculptor Capital LP | $237.0M | 3,000,000 | -1.9% | 2.22% |
| Jpmorgan Chase & Co | $230.8M | 2,743,850 | +5.7% | 2.03% |
| Alliancebernstein L.P. | $205.1M | 2,380,344 | +36.0% | 1.76% |
| Bank Of Montreal | $191.6M | 2,425,491 | +5.1% | 1.79% |
| Dimensional Fund Advisors LP | $187.3M | 2,369,310 | +33.9% | 1.75% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in GMED
20 disclosures of 22 on record · median 35d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -18.7%S&P +12.0% · vs S&P 500 -30.7% | Mar 3, 2026 | Apr 7, 2026 | 35d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +28.0%S&P +27.8% · vs S&P 500 +0.2% | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Lisa C. McClainSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +26.8%S&P +25.5% · vs S&P 500 +1.3% | Jun 24, 2025 | Aug 13, 2025 | 50d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +28.7%S&P +22.0% · vs S&P 500 +6.7% | Jul 10, 2025 | Aug 13, 2025 | 34d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +0.3%S&P +40.4% · vs S&P 500 -40.1% | Apr 9, 2025 | May 14, 2025 | 35d |
| Daniel S. Goldman | Stock | Sale | $15,001 - $50,000 | +25.9%S&P +88.5% · vs S&P 500 -62.7% | Mar 6, 2023 | Apr 17, 2023 | 42d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -3.2%S&P +85.7% · vs S&P 500 -88.9% | Feb 8, 2023 | Mar 17, 2023 | 37d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +1.3%S&P +92.8% · vs S&P 500 -91.6% | Jan 11, 2023 | Feb 17, 2023 | 37d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +27.8%S&P +96.3% · vs S&P 500 -68.5% | Jun 27, 2022 | Jul 7, 2022 | 10d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.6%S&P +91.9% · vs S&P 500 -69.3% | May 10, 2022 | Jun 10, 2022 | 31d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.7%S&P +83.5% · vs S&P 500 -70.8% | Jun 2, 2022 | Jun 10, 2022 | 8d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +36.4%S&P +149.5% · vs S&P 500 -113.1% | Jun 1, 2020 | Jun 16, 2020 | 15d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +34.8%S&P +151.7% · vs S&P 500 -116.9% | May 28, 2020 | Jun 10, 2020 | 13d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +75.2%S&P +196.0% · vs S&P 500 -120.7% | Mar 31, 2020 | Apr 16, 2020 | 16d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +34.6%S&P +128.7% · vs S&P 500 -94.0% | Feb 21, 2020 | Mar 10, 2020 | 18d |
| Josh GottheimerJointFiled late | Stock | Purchase | $1,001 - $15,000 | +68.1%S&P +152.7% · vs S&P 500 -84.6% | Jul 26, 2019 | Sep 16, 2019 | 52d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +63.1%S&P +153.8% · vs S&P 500 -90.6% | Jul 30, 2019 | Aug 19, 2019 | 20d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +38.3%S&P +175.7% · vs S&P 500 -137.4% | Jun 19, 2018 | Jul 25, 2018 | 36d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +37.0%S&P +174.6% · vs S&P 500 -137.6% | Jun 18, 2018 | Jul 25, 2018 | 37d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +49.0%S&P +187.8% · vs S&P 500 -138.7% | Apr 10, 2018 | Apr 27, 2018 | 17d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
2 members · estimate, as of Sep 10, 20262 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded GMED?
Gilbert Ray Cisneros, Jr., Lisa C. McClain, Josh Gottheimer, Daniel S. Goldman, Ro Khanna, Lois Frankel disclosed GMED transactions in the filings shown here.
Which members of Congress hold GMED?
2 members of Congress report a position in GMED in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are GMED trades disclosed?
Congressional disclosures took a median of 35 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.